Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 97

1.

Targeted comparative RNA interference analysis reveals differential requirement of genes essential for cell proliferation.

Machida YJ, Chen Y, Machida Y, Malhotra A, Sarkar S, Dutta A.

Mol Biol Cell. 2006 Nov;17(11):4837-45. Epub 2006 Sep 6.

2.

Global gene expression profiling unveils S100A8/A9 as candidate markers in H-ras-mediated human breast epithelial cell invasion.

Moon A, Yong HY, Song JI, Cukovic D, Salagrama S, Kaplan D, Putt D, Kim H, Dombkowski A, Kim HR.

Mol Cancer Res. 2008 Oct;6(10):1544-53. doi: 10.1158/1541-7786.MCR-08-0189.

3.

Allele-specific cancer cell killing in vitro and in vivo targeting a single-nucleotide polymorphism in POLR2A.

Mook OR, Baas F, de Wissel MB, Fluiter K.

Cancer Gene Ther. 2009 Jun;16(6):532-8. doi: 10.1038/cgt.2008.104. Epub 2009 Jan 23.

PMID:
19165236
4.

A tightly regulated and reversibly inducible siRNA expression system for conditional RNAi-mediated gene silencing in mammalian cells.

Wu RH, Cheng TL, Lo SR, Hsu HC, Hung CF, Teng CF, Wu MP, Tsai WH, Chang WT.

J Gene Med. 2007 Jul;9(7):620-34.

PMID:
17486668
5.

HOP/OB1/NECC1 promoter DNA is frequently hypermethylated and involved in tumorigenic ability in esophageal squamous cell carcinoma.

Yamashita K, Kim MS, Park HL, Tokumaru Y, Osada M, Inoue H, Mori M, Sidransky D.

Mol Cancer Res. 2008 Jan;6(1):31-41. doi: 10.1158/1541-7786.MCR-07-0213.

6.

Krüppel-like factor 5 promotes breast cell proliferation partially through upregulating the transcription of fibroblast growth factor binding protein 1.

Zheng HQ, Zhou Z, Huang J, Chaudhury L, Dong JT, Chen C.

Oncogene. 2009 Oct 22;28(42):3702-13. doi: 10.1038/onc.2009.235. Epub 2009 Aug 10.

PMID:
19668233
7.

Zinc-induced G2/M blockage is p53 and p21 dependent in normal human bronchial epithelial cells.

Wong SH, Shih RS, Schoene NW, Lei KY.

Am J Physiol Cell Physiol. 2008 Jun;294(6):C1342-9. doi: 10.1152/ajpcell.00061.2008. Epub 2008 Mar 19.

8.

Bystin in human cancer cells: intracellular localization and function in ribosome biogenesis.

Miyoshi M, Okajima T, Matsuda T, Fukuda MN, Nadano D.

Biochem J. 2007 Jun 15;404(3):373-81.

9.

Ablation of Stat3 by siRNA alters gene expression profiles in JEG-3 cells: a systems biology approach.

Jiang K, Krous LC, Knowlton N, Chen Y, Frank MB, Cadwell C, Centola M, Jarvis JN.

Placenta. 2009 Sep;30(9):806-15. doi: 10.1016/j.placenta.2009.06.006. Epub 2009 Jul 18.

PMID:
19616846
11.

Transcriptome profiling and network pathway analysis of genes associated with invasive phenotype in oral cancer.

Kang CJ, Chen YJ, Liao CT, Wang HM, Chang JT, Lin CY, Lee LY, Wang TH, Yen TC, Shen CR, Chen IH, Chiu CC, Cheng AJ.

Cancer Lett. 2009 Nov 1;284(2):131-40. doi: 10.1016/j.canlet.2009.04.014. Epub 2009 May 19.

PMID:
19457608
12.

Silencing of MBD1 and MeCP2 in prostate-cancer-derived PC3 cells produces differential gene expression profiles and cellular phenotypes.

Yaqinuddin A, Abbas F, Naqvi SZ, Bashir MU, Qazi R, Qureshi SA.

Biosci Rep. 2008 Dec;28(6):319-26. doi: 10.1042/BSR20080032.

PMID:
18666890
13.

Survivin gene RNA interference inhibits proliferation, induces apoptosis, and enhances radiosensitivity in HeLa cells.

Song H, Xin XY, Xiao F, Wang DT, Yue QH, Han X.

Eur J Obstet Gynecol Reprod Biol. 2008 Jan;136(1):83-9. Epub 2006 Nov 13.

PMID:
17098350
14.

Cholecystokinin down-regulation by RNA interference impairs Ewing tumor growth.

Carrillo J, García-Aragoncillo E, Azorín D, Agra N, Sastre A, González-Mediero I, García-Miguel P, Pestaña A, Gallego S, Segura D, Alonso J.

Clin Cancer Res. 2007 Apr 15;13(8):2429-40.

15.

MYC pathway is activated in clear cell renal cell carcinoma and essential for proliferation of clear cell renal cell carcinoma cells.

Tang SW, Chang WH, Su YC, Chen YC, Lai YH, Wu PT, Hsu CI, Lin WC, Lai MK, Lin JY.

Cancer Lett. 2009 Jan 8;273(1):35-43. doi: 10.1016/j.canlet.2008.07.038. Epub 2008 Sep 21.

PMID:
18809243
16.

Microarray analysis identifies differentially expressed genes induced by human papillomavirus type 18 E6 silencing RNA.

Min W, Wen-li M, Zhao-hui S, Ling L, Bao Z, Wen-ling Z.

Int J Gynecol Cancer. 2009 May;19(4):547-63. doi: 10.1111/IGC.0b013e3181a44c68.

PMID:
19509549
17.

Promoter hypermethylation of the SFRP2 gene is a high-frequent alteration and tumor-specific epigenetic marker in human breast cancer.

Veeck J, Noetzel E, Bektas N, Jost E, Hartmann A, Knüchel R, Dahl E.

Mol Cancer. 2008 Nov 6;7:83. doi: 10.1186/1476-4598-7-83.

18.

Identification and transcript analysis of a novel wallaby (Macropus eugenii) basal-like breast cancer cell line.

Sharp JA, Mailer SL, Thomson PC, Lefèvre C, Nicholas KR.

Mol Cancer. 2008 Jan 7;7:1. doi: 10.1186/1476-4598-7-1.

19.

Inhibitor of differentiation 4 (Id4) is a potential tumor suppressor in prostate cancer.

Carey JP, Asirvatham AJ, Galm O, Ghogomu TA, Chaudhary J.

BMC Cancer. 2009 Jun 7;9:173. doi: 10.1186/1471-2407-9-173.

20.

Peripheral-type benzodiazepine receptor overexpression and knockdown in human breast cancer cells indicate its prominent role in tumor cell proliferation.

Li W, Hardwick MJ, Rosenthal D, Culty M, Papadopoulos V.

Biochem Pharmacol. 2007 Feb 15;73(4):491-503. Epub 2006 Oct 29.

PMID:
17126818

Supplemental Content

Support Center